Cervical Cancer Screening Market will reach US$ 34.92 Billion by 2028, driven by Increased Public Awareness and Technological Breakthroughs in Screening
Global Cervical Cancer Screening Market was US$ 26.7 Billion in 2022 according to Renub Research. Worldwide, cervical cancer is the fourth most diagnosed cancer and the fourth leading cause of cancer death in women. Cervical cancer is driven by persistent disease with a sexually disseminated infection and high-risk types of (HPV) human papillomavirus. Cervical cancer is … Read more